Clinical trial
A Phase 1/2 Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
NCT02750891 is registered in ClinicalTrials.gov with Sumitomo Pharma Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
- Lead sponsor
- Sumitomo Pharma Co., Ltd.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- January 31, 2020
- Enrollment
- 18 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.